Marketing of Pharmaceutical products declined in the last decade
Researchers have found a decline in the pharmaceutical advertising to physicians and consumers, which is still present in some aspects
Read morepharmaceutical company
China’s pharmaceutical industry is improving economically
China has a booming pharmaceutical industry. Its low rate medicines with good quality are increasingly gaining popularity in every part
Read moreChronic Obstructive Pulmonary Disease has gotten another foe
QVA149, trial medicine by Novartis for the treatment of chronic obstructive pulmonary disease (COPD), has achieved the required therapeutic targets
Read moreRoche has expanded the tender offer for Illumina
Roche, a Switzerland based company specialized in pharmaceuticals and diagnostics, has announced that the tender offer for Illumina has been
Read moreOrexigen has reached at an agreement with FDA for its drug Contrave
Orexigen Therapeutics Inc., biopharmaceutical company, has announced on Monday that it has reached at an agreement with the U.S. Food
Read moreFDA has approved Kalydeco; a drug for the treatment of cystic fibrosis
U.S. Food and Drug Administration (FDA) has approved “Kalydeco or VX-770” (ivacaftor) by Vertex Pharmaceuticals as reported by the company
Read moreBiogen Idec, biopharmaceutical company, has seen increased profits in Q4
Biogen Idec Inc., Biopharmaceutical company and the world’s largest maker of medicines for multiple sclerosis, has released its full year
Read morePharmaceutical companies have come together to fight against Neglected diseases
Major pharmaceutical companies of the world has joined hands along with governments and leading global health organizations on Monday to
Read moreBristol-Myers Squibb (BMS) has reported increased profit in the fourth quarter
Bristol-Myers Squibb (BMS) Co. has reported an increase of 76% of profits in its fourth-quarter on Thursday. According to the
Read moreNovartis has reported its Q4 2011 results, showing decline in profit
Novartis AG, Swiss pharmaceuticals, has reported that the company’s profit may decline by 46% to $1.2 billion on charges in
Read more